Satoru Kuroda
Director Técnico/Científico/I+D en Aphoenix, Inc. .
Perfil
Satoru Kuroda is currently the Chief Technology Officer at Aphoenix, Inc. Prior to this, he worked as a Principal at Astellas Pharma, Inc. He received his undergraduate degree in 1986 and his doctorate degree in 1999 from Kyushu University.
Cargos activos de Satoru Kuroda
| Empresas | Cargo | Inicio |
|---|---|---|
Aphoenix, Inc.
 Aphoenix, Inc. Medical/Nursing ServicesHealth Services Aphoenix, Inc. is a holding company that operates as a chemical genomics firm. It specializes in the affinity purification technology using special nano-scale beads and other supporting technologies, such as medicinal chemistry, mass spectroscopy, informatics and molecular, biology. The firm exploits drugs, which lack known mechanisms of action as probes for discovering druggable targets, and then develop such compounds against validated targets. The company was founded in 2002 and is headquartered in Tokyo, Japan . | Director Técnico/Científico/I+D | 27/04/2009 |
Antiguos cargos conocidos de Satoru Kuroda.
| Empresas | Cargo | Fin |
|---|---|---|
| ASTELLAS PHARMA INC. | Corporate Officer/Principal | - |
Formación de Satoru Kuroda.
| Kyushu University | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| ASTELLAS PHARMA INC. | Health Technology |
| Empresas privadas | 1 |
|---|---|
Aphoenix, Inc.
Aphoenix, Inc. Medical/Nursing ServicesHealth Services Aphoenix, Inc. is a holding company that operates as a chemical genomics firm. It specializes in the affinity purification technology using special nano-scale beads and other supporting technologies, such as medicinal chemistry, mass spectroscopy, informatics and molecular, biology. The firm exploits drugs, which lack known mechanisms of action as probes for discovering druggable targets, and then develop such compounds against validated targets. The company was founded in 2002 and is headquartered in Tokyo, Japan . | Health Services |
- Bolsa de valores
- Insiders
- Satoru Kuroda
